- Docket No.
- 26-2165
- Appellate Court
- Fourth Circuit
Goal
- Block enforcement of an agency action
- Compel agency action
- Declaration that an agency action is unlawful
- Vacate agency action
Issues
Litigation Content
Why This Matters:
Why This Matters
The plaintiffs argue that the Inflation Reduction Act’s Medicare drug negotiation process violates the Administrative Procedure Act. Medicare’s authority to negotiate the price of certain single-source, high-priced drugs is estimated to result in substantial savings for Medicare beneficiaries and the federal government. This appeal challenges the district court’s ruling that CMS’s definition of qualifying single-source drug does not violate the APA.
Potential Impact:
Potential Impact
Successful challenges to Medicare’s negotiation authority would negate savings to Medicare beneficiaries and taxpayers and could severely restrict federal regulatory authority in the health care arena.